Merlin_Asset (@Merlin_Asset) header
Merlin_Asset (@Merlin_Asset) profile picture

“Always Be Learning” - Tweets are not recommendation. Do your own due diligence. Sector and Market Cap Agnostic

Joined April 2015
Photo by Merlin_Asset (@Merlin_Asset)Photo by Merlin_Asset (@Merlin_Asset)Photo by Merlin_Asset (@Merlin_Asset)Photo by Merlin_Asset (@Merlin_Asset)Photo by Merlin_Asset (@Merlin_Asset)Photo by Merlin_Asset (@Merlin_Asset)Photo by Merlin_Asset (@Merlin_Asset)Photo by Merlin_Asset (@Merlin_Asset)Photo by Merlin_Asset (@Merlin_Asset)Photo by Merlin_Asset (@Merlin_Asset)
Capricor $CAPR -68% after hours. FDA rejected deramiocel for Duchenne. It was telegraphed: - July: FDA panel voted 9-3 that the data didn't show efficacy - FDA staff flagged that Capricor changed its analysis after the trial ended I guess lesson is when the analysis plan moves after unblinding, so does your stock.
2
690
Merlin_Asset retweeted
$ABVX ha you've got to be kidding me. The lawyers have made them give up the game:
1
4
2
29
2,837
Bought $ABVX at $67 on the short-report dip. A once-daily UC pill with 51% remission vs 10% placebo at week 44. NDA due by year-end. And Big Pharma has a patent cliff to fill. Scorpion's betting on a safety scare and likely covered their short given the move. $XBI
3
347
Merlin_Asset retweeted
AI bros are finally learning what it’s like to be a commodity bro.
10
22
4
402
23,314
Merlin_Asset retweeted
Disappointing it took the media this many years to report this - plane loads of refugees were flown to Montreal for free, month after month, year after year, and put into mid-range hotels with free room service, free Internet, free nurses, free house-keeping. And health care.
FIRST READING: Free health care to refugee claimants now costing $2 million per day nationalpost.com/opinion/fir…
49
469
24
1,584
58,238
On the weekend the FDA rejected $SMMT drug. PFS win, but OS missed: HR 0.79, p=0.057. Not enough. 48 hours later Sellas $SLS hits OS outright in AML: 24.0 vs 14.7 months median survival HR 0.59, p=0.035 The catch: 126 patients, 80 deaths. A small trial, but on the right endpoint. The FDA just told everyone which endpoint it pays for. Sellas plans its BLA for 1H 2027
1
332
This must be the reason copper is rolling over. Clearly bringing on too much supply!
Britain's copper crime wave has become brazen and out of control, with thieves filming themselves slicing out cables all over the country to cash in on the precious metal inside. @TomSkyNews investigates. 📺 trib.al/hO3OZDT
1
1
368
Merlin_Asset retweeted
Confirmed: he blew up, loaded up on calls hoping to make it all back quick, then blew up again.
He's baaaaack: "Somebody" just spent $100MM premium on 2 week AI Stock Calls for the Oct2 expiration: INTC Oct2nd 115c bot up to 3.65 20k $7.3MM MRVL Oct2nd 250c bot 11.00 3500x $3.85MM SNDK Oct2nd 1600c bot up to 97.60 4200x $41MM MU oct 2nd 1000c bot up to 44.00 10k $44MM
529
865
287
12,231
1,399,797
The regulator reads the pre-specified analysis, not the follow-up you wish you'd planned. FDA just told $SMMT that PFS isn't enough. China approved the same drug in the same setting in May 2024. Same drug, different bar. $XBI
83
Canadian Natural Resources $CNQ.TO said it agreed to acquire Advantage Energy $AAV.TO for CA$13.55 ($9.49) per share in cash.
132
Quebecor’s $QBR.B.TO offer is worth about C$19.45 per share, valuing Telus $T.TO at around C$31 billion ($21.7 billion). That would be a 60% premium to Friday’s closing share price.
216
Summit $SMMT announced the FDA rejection today for ivonescimab plus chemo in EGFR-mutated lung cancer patients whose earlier targeted drugs stopped working. The FDA wanted a statistically significant survival benefit, and HARMONi didn't show one. $XBI
1
384
CANACCORD $CF.TO ENTERS INTO AGREEMENT TO BE TAKEN PRIVATE BY CHAIRMAN AND CEO DAN DAVIAU Shareholders to receive aggregate consideration of $15.27 per common share comprised of $7.45, plus proceeds of £4.15
3
4
19
4,913
This is the exact issue with AI Drug Discovery. They still have to “operate at the speed of life”. It still takes years to run a clinical trial. $XBI $LLY
Will AI cure all diseases over the next decade? We asked @BenjamineYLiu.
1
104
Merlin_Asset retweeted
Ok let me get this straight: - The most charismatic CEO in AI, who happens to be an open source proponent (which is obviously bad for Frontier models), gets ousted because of “surprise” leaks about his affair(s) - Microsoft suffers a global outage, just a few days after Anthropic unveils an Office competitor - just as Anthropic is about to IPO … and none of you think this is weird at all?!! The Golden Age of Rift ™️ is upon us
73
138
21
1,422
87,564
Altius Minerals to Acquire TNR Gold in C$122 Million Cash The deal represents an implied consideration of about C$0.48 per TNR share, a 60% premium to the stock's closing price on Tuesday, which is listed on the TSX Venture Exchange Congrats @YellowLabLife on surfacing the value.
2
1
6
633
Mirum $MIRM brelovitug in hepatitis delta. Second Phase 3 win in two months. AZURE-4 at week 24: 300 mg weekly: 59% hit the combined endpoint 900 mg monthly: 44% Delayed-treatment arm: 0% The real story is the 108-week data in cirrhosis patients, with 100% virologic response and 100% ALT normalization (only 15 patients). Half of these patients are cirrhotic and there's no approved HDV drug in the US. BLA is planned for H1 2027, and Vir is chasing the same market.
92
For the first time in decades, America is about to start refining raw tin at scale. A first-of-its-kind plant in Henry County, Virginia, is set to begin production in 2027. A new deal secures its supply: up to 3,600 metric tons a year from the Democratic Republic of the Congo. Tin holds together the circuit boards in your phone, your car, and our defense systems. American workers will now smelt Congolese tin in the United States, creating jobs on both sides of the Atlantic. That is Pax Silica and the U.S.-DRC Strategic Partnership Agreement at work. mining.com/alphamin-directs-…
151
456
88
1,351
159,750